Renal Biomarkers: Technologies and Global Markets

Report Code: BIO138B

Publish Date: Jan 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $2750

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for renal biomarkers is estimated to increase from $1.2 billion in 2022 to reach $1.7 billion by 2027, at a compound annual growth rate (CAGR) of 7.6% from 2022 through 2027.

Report Includes

  • 41 data tables and 24 additional tables
  • A detailed overview and up-to-date analysis of the global markets for renal biomarkers
  • Analyses of the global market trends, with market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for renal biomarkers market, and corresponding market share analysis by assay type, application, end user, and region
  • Updated information on market drivers and opportunities for renal biomarkers, key shifts, regulations and industry specific challenges, and other demographic factors that will shape the market demand over the coming years (2022-2027)
  • Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages
  • Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
  • Patent activity and review of patent grants for biomarkers and related technologies
  • Descriptive company profiles of the market leading players, including BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec, and BioPorto

Report Scope

This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the CAGR for renal biomarkers.

The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers. All types of renal biomarkers have been considered in research, clinical trials and for diagnostic purposes.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW) region. For market estimates, data is provided for 2021 as the base year, 2022 and forecast through year-end 2027.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $1.1 billion
Market size forecast $1.7 billion
Growth rate CAGR of 7.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Segment, Region, Country, Type, End-User, and Technique
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, France, Germany, UK, Italy, Spain, China, Australia, and Japan
Key Market Drivers
  • Prevalence of Chronic Kidney Diseases
  • Rising Cases of Acute Kidney Injury
  • Renal Biomarker Applications in Clinical Trials
  • Aging Increases the Prevalence of Kidney Diseases
  • Increasing Awareness of Kidney Diseases
  • Availability of New Biomarkers
Companies studied
ABBOTTBECKMAN COULTER (SUBSIDIARY OF DANAHER CORP.)
BIOMERIEUXBIOPORTO A/S
BIO-RAD LABORATORIES INC.ENZO BIOCHEM INC.
GENTIAN DIAGNOSTIC ABHYTEST LTD.
NEPHROSANTNEXELIS
PROTEOMICS INTERNATIONAL LABORATORIES LTD.RANDOX LABORATORIES LTD.
F. HOFFMANN-LA ROCHE LTD.SPHINGOTEC
THERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The renal biomarker market is projected to grow from $1.1 billion in 2021 to $1.7 in 2027, at a compound annual growth rate (CAGR) of 7.6% during the forecast period.
The key factors driving the growth of renal biomarker market includes , the increasing prevalence of AKI, aging population trend is leading to deterioration of kidney health and incidence of CKD are on a rise.
The renal biomarker market is segmented based on type, technique, end user and region.
Filtered renal biomarkers will dominate the market during the forecasting period.
North America holds the highest share in the market.
Key companies in the market includes Abbot, Bio-rad, Biomerieux, ThermoFischer Scientific and Proteomics International.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Renal Biomarkers: Technologies and Global Markets93Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market Overview19Free
Chapter- 4: Impact of COVID-19 Pandemic6Free
Chapter- 5: Global Renal Biomarker Market by Type8Free
Chapter- 6: Global Market for Renal Biomarkers by Region22Free
Chapter- 7: Renal Biomarker Market by End User 2Free
Chapter- 8: Renal Biomarker Market by Technique 4Free
Chapter- 9: Competitive Landscape3Free
Chapter- 10: Company Profiles17Free
Chapter- 11: Patent Review3Free
Chapter- 12: Clinical Trial Analysis2Free
Published - Jan-2015| Analyst - Cheng-Yuk Lee| Code - BIO138A

Report Highlights

The in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019.

Report Includes

  • A comprehensive analysis of renal biomarkers global markets and technologies.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Details pertaining to the history and current state of chronic kidney disease (CKD), background information on renal biomarkers, and current industrial technologies used for diagnosis.
  • In-depth analyses of the predominant biomarkers in the market, namely creatinine, and emerging biomarkers like NGAL, KIM-1, L-FABP and many others.
  • Discussion concerning intellectual property, the regulatory requirement, and the competitive landscape of the industry.
  • Comprehensive profiles of major players in the renal biomarkers field.

Related Reports

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Oncology Biomarkers: Global Markets

Published - Jul 2023 | Publisher - BCC Publishing | Code - BIO244A

The global oncology biomarkers market reached $15.5 billion in 2022, should reach $17.6 billion by 2023 and $35.2 billion by 2028 with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2023-2028.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Published - May 2023 | Publisher - BCC Publishing | Code - BIO074D

The global central nervous system (CNS) biomarkers market should reach $9.5 billion by 2027 from $5.7 billion in 2022 at a compound annual growth rate (CAGR) of 10.8% for the forecast period of 2022 to 2027.

Cardiac Biomarkers: Technologies and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - BIO128D

The global market for cardiac biomarkers is estimated to increase from $13.4 billion in 2022 to reach $23.8 billion by 2027, at a compound annual growth rate (CAGR) of 12.2% from 2022 through 2027.

Recent Reports

In Vitro Diagnostics (IVD) Quality Controls: Global Market

Published - Aug 2024 | Publisher - Partha Sarathi Das | Code - BIO233B

The global market for In Vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

RNAi Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO127C

The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.

Metabolomics: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Global Recombinant Proteins Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO254A

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Plastics Recycling: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - PLS031E

The global market for plastic recycling is expected to grow from $42.4 billion in 2024 to $57.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Renal Biomarkers: Technologies and Global Markets
Sample Report